Goldman Sachs reports 4.8% stake in Delek US
The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC report beneficial ownership of 2,905,695.04 shares of Delek US Holdings, Inc. common stock, representing 4.8% of the class as of 12/31/2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC report beneficial ownership of 2,905,695.04 shares of Delek US Holdings, Inc. common stock, representing 4.8% of the class as of 12/31/2025.
The filing shows no sole voting or dispositive power and shared voting power over 2,905,312.04 shares and shared dispositive power over 2,905,427.04 shares. The reporting parties certify the position is held in the ordinary course of business and not for the purpose of changing or influencing control of Delek US Holdings.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What ownership stake in Delek US Holdings (DK) does Goldman Sachs report?
Which Goldman Sachs entities are listed as reporting persons for Delek US (DK)?
Does Goldman Sachs state any intent to influence control of Delek US Holdings (DK)?
Why is this Delek US (DK) filing classified as Schedule 13G/A rather than 13D?
What clarifications about beneficial ownership does Goldman Sachs provide in the exhibits?
AI-generated analysis. How Rhea-AI works. Not financial advice.